Transcriptional response of a human colon adenocarcinoma cell line to sodium butyrate

Biochem Biophys Res Commun. 2001 Aug 3;285(5):1280-9. doi: 10.1006/bbrc.2001.5323.

Abstract

Taking advantage of the DNA array screening technology, we analysed the effect of sodium butyrate on mRNA transcription in human HT29 colon adenocarcinoma cells. Out of 588 mRNA species analysed, only 119 resulted expressed. Among these, 60 exhibited a variable degree of modulation after butyrate treatment. Genes linked to the cell growth, apoptosis and oxidative metabolism appeared the most significantly affected. Furthermore, many of the differentially expressed genes are transcription factors and this may account for the variability of the biological effects of butyrate. The pattern of butyrate-affected genes may represent a reference in further analyses of gene expression of intestinal cells and tissues.

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / metabolism
  • Adenocarcinoma / pathology
  • Apoptosis / genetics
  • Butyrates / pharmacology*
  • Cell Cycle / drug effects
  • Cell Differentiation / drug effects
  • Cell Division / drug effects
  • Cell Division / genetics
  • Colonic Neoplasms / drug therapy*
  • Colonic Neoplasms / metabolism
  • Colonic Neoplasms / pathology
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins / metabolism
  • Gene Expression / drug effects
  • Gene Expression Profiling
  • HT29 Cells
  • Humans
  • Oligonucleotide Array Sequence Analysis
  • Oxidation-Reduction
  • RNA, Messenger / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transcription Factors / genetics
  • Transcription Factors / metabolism
  • Transcription, Genetic / drug effects*

Substances

  • Butyrates
  • CDKN1A protein, human
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins
  • RNA, Messenger
  • Transcription Factors